CPHI & PMEC China 2026
06/2026 – 06/2026
Über das Unternehmen
- Firmenname (rechtlich): WUHAN HUST LIFE SCIENCE & TECHNOLOGY CO ., LTD.
- Registrierungsland: China
- Adresse: HUST SCIENCE PARK , EAST LAKE HIGH-TECH DEVELOPMENT, Building 1, No. 3, Road 4, Wuhan,
- Anzahl der Mitarbeiter: 50 - 99
Beschreibung:
HUSTLIFE SciTech is a pharmaceutical manufacturer focused on polysaccharide and protein macromolecule drugs, including hydroxyethyl starch, iron protein succinylate and icodextrin. For hydroxyethyl starch, the company has obtained GMP and CEP certification and registered in Russia, Ukraine, India and Mexico, exporting to dozens of countries; for icodextrin, it has obtained China GMP, submitted a DMF with a European client in 2023, and received a Phase II assessment report recommended for approval, with a goal of becoming the largest polysaccharide polymer API production base in China.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
HerstellerVertriebspartnerAPI-Hersteller
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerVertriebspartnerAPI-Hersteller
Absatzmärkte
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy
Hauptprodukte/-dienstleistungen
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Proofs
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen